Latest Breaking News On - Artax biopharma - Page 1 : comparemela.com

Artax Announces First Patient Dosed in Phase 2a Psoriasis Trial Evaluating AX-158

/PRNewswire/ Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of autoimmune diseases, today announces.

United kingdomUnited statesArtax biopharmaJamesg kruegerRob armstrongCompany phaseAdvent life sciencesHead of the laboratory for investigative dermatologyPrnewswire artax biopharma incRockefeller universityEfficacy results are expectedSecond halfClass nck blockerAutoimmune diseaseBroad potentialTreat many autoimmune diseases

Sapreme Appoints Experienced Industry Executives, Dr Jeanne Bolger and Dr Andre Hoekema, to its Bo

UTRECHT, The Netherlands (BUSINESS WIRE) Sapreme, a biotechnology company focused on improving the delivery and efficacy of macromolecule therapeutics, today announced the appointment of experienced biopharmaceutical industry executives Jeanne Bolger, MD, and Andre Hoekema, PhD, to its Board of Directors. Both bri.

Andre hoekemaEva maria mulderJeanne bolgerArtax biopharmaUniversity college dublinCorporate development europe at invitrogen corporationBusiness development at crucellLeiden universityTrophic communicationsGuy hermansChief executive officerVice president venture investingUniversity collegeLife healthcareChief business officerManaging director

Sapreme Appoints Experienced Industry Executives, Dr Jeanne Bolger and Dr Andre Hoekema, to its Board of Directors

Sapreme Appoints Experienced Industry Executives, Dr Jeanne Bolger and Dr Andre Hoekema, to its Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Jeanne bolgerAndre hoekemaArtax biopharmaEva maria mulderBusiness development at crucellTrophic communicationsUniversity college dublinCorporate development europe at invitrogen corporationLeiden universityGuy hermansChief executive officerVice president venture investingUniversity collegeLife healthcareChief business officerManaging director

Artax Biopharma Announces Positive Phase 1 Results for AX-158, Company s First-in-Class Oral Immunomodulator Developed to Treat T Cell-Mediated Diseases

/PRNewswire/ Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of T Cell-mediated diseases, today.

United kingdomJoseph lobackiClinical development effortsPrnewswire artax biopharma incFindings demonstratedInvestigational agentWell toleratedAll dosesStrongly supports further clinical developmentBeing developedOnce daily oral dosingAddress autoimmune diseasesProviding immunomodulationOfficer josephArtax biopharmaHealth care amp hospitals

Artax Biopharma Appoints Andre Hoekema, Ph D , to Company s Board of Directors

/PRNewswire/ Artax Biopharma, Inc., a clinical stage biotechnology company focused on transforming the treatment of T-cell-mediated diseases, today.

United kingdomAndre hoekemaArtax biopharmaJoseph lobackiCompany board of directorsGenentech incLeiden universityPrnewswire artax biopharma incInvitrogen corporationLife sciencesCorporate development europeCompany welcomes drCompany mergers acquisitionsBusiness developmentBiotech veteranTrack record